BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38299551)

  • 1. Challenges for further successful development of tumor necrosis factor targeting therapies for uveitis.
    Thng ZX; Regenold J; Bromeo AJ; Akhavanrezayat A; Than NTT; Khatri A; Mohammadi SS; Tran ANT; Shin YU; Karaca I; Ghoraba HH; Or CCM; Nguyen QD
    Expert Opin Investig Drugs; 2024 Feb; 33(2):95-104. PubMed ID: 38299551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Knowledge of Biologics in Treatment of Noninfectious Uveitis.
    Gupta S; Shyamsundar K; Agrawal M; Vichare N; Biswas J
    J Ocul Pharmacol Ther; 2022 Apr; 38(3):203-222. PubMed ID: 35133890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the systemic management of noninfectious uveitis in children and adolescents.
    Leal I; Steeples LR; Wong SW; Giuffrè C; Pockar S; Sharma V; Green EKY; Payne J; Jones NP; Chieng ASE; Ashworth J
    Surv Ophthalmol; 2024; 69(1):103-121. PubMed ID: 36682467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower Relapses Rate With Infliximab Versus Adalimumab in Sight-Threatening Uveitis: A Multicenter Study of 330 Patients.
    Maalouf G; Andrillon A; Leclercq M; Sève P; Bielefeld P; Gueudry J; Sené T; Titah C; Moulinet T; Rouvière B; Sène D; Desbois AC; Domont F; Touhami S; Thibault T; Chamieh CE; Cacoub P; Kodjikian L; Biard L; Bodaghi B; Saadoun D
    Am J Ophthalmol; 2022 Jun; 238():173-180. PubMed ID: 35172172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics.
    Thomas AS
    Curr Opin Ophthalmol; 2019 May; 30(3):138-150. PubMed ID: 30844945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives for immunotherapy in noninfectious immune mediated uveitis.
    Touhami S; Gueudry J; Leclercq M; Touitou V; Ghembaza A; Errera MH; Saadoun D; Bodaghi B
    Expert Rev Clin Immunol; 2021 Sep; 17(9):977-989. PubMed ID: 34264142
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-Tumor Necrosis Factor Treatment in the Management of Pediatric Noninfectious Uveitis: Infliximab Versus Adalimumab.
    Ucan Gunduz G; Yalcinbayir O; Cekic S; Yildiz M; Kilic SS
    J Ocul Pharmacol Ther; 2021 May; 37(4):236-240. PubMed ID: 33512278
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis.
    Liu W; Bai D; Kou L
    BMC Ophthalmol; 2023 May; 23(1):240. PubMed ID: 37248486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adalimumab in the treatment of non-infectious uveitis.
    Burek-Michalska A; Turno-Kręcicka A
    Adv Clin Exp Med; 2020 Oct; 29(10):1231-1236. PubMed ID: 33125196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders.
    Levy-Clarke G; Jabs DA; Read RW; Rosenbaum JT; Vitale A; Van Gelder RN
    Ophthalmology; 2014 Mar; 121(3):785-96.e3. PubMed ID: 24359625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor necrosis factor agents in psoriasis: addressing key challenges using biosimilars.
    Prignano F; Choi J; Pieper B; Iversen L
    Expert Opin Biol Ther; 2021 Jan; 21(1):75-80. PubMed ID: 32886008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of intravitreal anti-tumour necrosis factor drugs in adults with non-infectious uveitis - a systematic review.
    Leal I; Rodrigues FB; Sousa DC; Romão VC; Duarte GS; Carreño E; Dick AD; Marques-Neves C; Costa J; Fonseca JE
    Acta Ophthalmol; 2018 Sep; 96(6):e665-e675. PubMed ID: 29577629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis-Related Uveitis in Patients under Anti-TNF-alpha Therapy: A Case Series.
    Hernanz I; Miguel Escuder L; Chamorro L; Moll-Udina A; Espinosa G; Sainz de la Maza M; Llorenç V; Adán A
    Ocul Immunol Inflamm; 2022 May; 30(4):839-844. PubMed ID: 33216652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotherapies in Uveitis.
    Leclercq M; Desbois AC; Domont F; Maalouf G; Touhami S; Cacoub P; Bodaghi B; Saadoun D
    J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33171664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Adalimumab and Infliximab for Noninfectious Uveitis.
    Tai F; Mehraban Far P; Pechlivanoglou P; Ramsay LC; Georgakopoulos JR; Sander B; Derzko-Dzulynsky LA; Felfeli T
    Ophthalmology; 2022 Mar; 129(3):357-359. PubMed ID: 34634363
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety of systemic therapy for noninfectious uveitis.
    Ormaechea MS; Hassan M; Onghanseng N; Park JH; Mahajan S; Al-Kirwi KY; Uludag G; Halim MS; Schlaen A; Sepah YJ; Do DV; Nguyen QD
    Expert Opin Drug Saf; 2019 Dec; 18(12):1219-1235. PubMed ID: 31801415
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent advances in uveitis therapy: focus on selected phase 2 and 3 clinical trials.
    Thng ZX; Bromeo AJ; Mohammadi SS; Khatri A; Tran ANT; Akhavanrezayat A; T T Than N; Nguyen KS; Yoo WS; Mobasserian A; Or CCM; Nguyen QD
    Expert Opin Emerg Drugs; 2023 Dec; 28(4):297-309. PubMed ID: 38129984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-TNF-α in the treatment of uveitis in the Besançon Hospital].
    Fery-Blanco C; Schwartz C; Gil H; Curlier E; Prati C; Delbosc B
    J Fr Ophtalmol; 2011 Dec; 34(10):697-702. PubMed ID: 21889230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidrug Antibodies to Tumor Necrosis Factor α Inhibitors in Patients With Noninfectious Uveitis.
    Bellur S; McHarg M; Kongwattananon W; Vitale S; Sen HN; Kodati S
    JAMA Ophthalmol; 2023 Feb; 141(2):150-156. PubMed ID: 36547953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current status of biological treatment for uveitis.
    Gaggiano C; Sota J; Gentileschi S; Caggiano V; Grosso S; Tosi GM; Frediani B; Cantarini L; Fabiani C
    Expert Rev Clin Immunol; 2020 Aug; 16(8):787-811. PubMed ID: 32700605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.